ChemDiv chemistry of cures

As a pioneer in discovery libraries, ChemDiv has started its diverse collection in 1991 by compiling heterocyclic compounds from all over the world, and later launching its own large-scale library synthesis program. Today, ChemDiv is the global leader in discovery chemistry. We have built the industry’s largest and most diverse collection of over 1,500,000 individually crafted, lead-like, drug-like small molecules.  This collection is steadily growing at a rate of over 16,000 compounds a month, exclusively synthesized in-house. Our novel chemistry is designed by a group of experts and is finely balanced with maximal diversity, bioactivity against particular targets, template novelty and robust IP position. Our collection represents the derivatives of all known 5-, 6- and 7-member N-, O-, S-, N,O-, N,S-, S,O- heterocycles.  We also enhance the set by the exclusive and rare heterocycles originally synthesized at our labs.  In addition to that, we offer the unique and special libraries including fragments set and Targeted diversity® set. Our CHeST library (Constructs Helpful SingleTones and Templates) is an exceptional spot that helps to open ‘terra incognita’ in the Chemical space.

Being focused on discovery chemistry for over a decade, we understand our customers’ needs and the peculiarities of bioscreening – the next link in the drug discovery where our libraries are used. ChemDiv is known for its high-quality customer service, flexible business models and a variety of formatting, packaging and delivery options.  We effectively support the subsequent steps of lead optimization by providing our customers with a broad range of custom chemistry solutions, synthetic protocols, building blocks as well as all medicinal chemistry tools that include focused libraries discovery and hit to lead compounds optimization.

see also:

---

Chemistry On Demand ™
Synthetic Chemistry
Medicinal Chemistry
Screening Libraries - Drug-Like
Screening Libraries - Unique CHeST collection
Chemistry Services